The fact that patients with RB predominantly carried the DMN3TA A/C genotype is consistent with our prior findings that DNA methylation and epigenetic status governs integrated regulation of T and B cell function, and IL-10 expression shaping PB vs. RB outcomes. The gene discussed is IL10; the disease is retinoblastoma.